Incidence and clinical course of thrombotic thrombocytopenic purpura due to ticlopidine following coronary stenting. EPISTENT Investigators. Evaluation of Platelet IIb/IIIa Inhibitor for Stenting.

Source:http://linkedlifedata.com/resource/pubmed/id/10071001

JAMA 1999 Mar 3 281 9 806-10

Download in:

View as

General Info

PMID
10071001